検索に戻る
案件記録
Targeting the Interplay of Treg Cells and Hepatic Stellate Cells in Liver Fibrosis and Insulin Resistance
発明審査中
4閲覧数
14請求項 · 4 独立
§ Ⅰ
案件概要
出願人
The Trustees of Columbia University in the City of New York
発明者
Nicholas ARPAIA; Thomas SAVAGE
IPC分類
C7K 16/24A61K 39/A61P 5/50
CPC分類
C7K16/248A61P5/50A61K2039/505C7K2317/24
Methods of treating subjects suffering from non-alcoholic steatohepatitis (NASH) by interfering with epidermal growth factor (EGFR) and interleukin 6 (IL-6) production and/or function in hepatic stellate cells.
原文(中国語)
Methods of treating subjects suffering from non-alcoholic steatohepatitis (NASH) by interfering with epidermal growth factor (EGFR) and interleukin 6 (IL-6) production and/or function in hepatic stellate cells.
外部リソース